Ebos Group Limited · NZX:EBO
Ebos — Shareholder Meeting (October 2017)
21 slides from Ebos's shareholder meeting presentation, Oct 17, 2017
Slide 1: 95th Annual Meeting
For personal use only 95th Annual Meeting 17 October 2017 1
Slide 2: Important Information
Important Information The information in this presentation was prepared by EBOS Group Ltd with due care and attention. However, the information is supplied in summary For personal use only form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness
Slide 3: 2017 Annual Meeting: Chairman – Mr Mark Waller
For personal use only 2017 Annual Meeting 1 Chairman – Mr Mark Waller 3
Slide 4: Agenda
Agenda • Welcome For personal use only • Introducing members of the Board • Presentations – Mark Waller, Chairman – Patrick Davies, Chief Executive Officer • Business of meeting • Conclusion 4
Slide 5: Board of Directors
Board of Directors For personal use only Mark Waller Independent Chairman of Directors Appointed 1987 Appointed Chairman 2015 Elizabeth Coutts Stuart McGregor Sarah Ottrey Peter Williams Independent Director Non-executive Director Independent Director Non-executive Director Joined 2003 Joined 2013 J
Slide 6: FY17 Summary Results
FY17 Summary Results For personal use only Reported Underlying ¹ NZD $m FY 2017 FY 2016 % FY 2017 FY 2016 ² % change change Revenue 7,625.9 7,101.5 7.4% 7,625.9 6,967.2 9.5% EBITDA 234.4 225.5 4.0% 241.4 220.4 9.6% NPAT 133.3 127.0 4.9% 138.6 124.2 11.6% Total 63 cents 58.5 cents 7.7% 63 cents 58.5
Slide 7: Results post the transformational Symbion deal
It is now 4 years post the transformational Symbion deal We continue to deliver results while reinvesting for growth Investments made Results achieved For personal use only (NZ$m) Underlying EBITDA Underlying EPS cents per share NZ$m $470m+ over 241 FY17 FY17 91.3 last 4 years FY16 225 FY16 84.0 4 Y
Slide 8: Business Segment overview
Business Segment overview Revenue Split – FY17 ANIMAL CARE For personal use only 15% New Zealand Animal Care 15% Australia Consumer Products 6% Pharmacy 50% Contract (Wholesale Logistics 8% and Retail) EBITDA Split – FY17 New Zealand Institutional Healthcare 21% Australia HEALTH CARE Data based on F
Slide 9: 2017 Annual Meeting: CEO – Mr Patrick Davies
For personal use only 2017 Annual Meeting 2 CEO – Mr Patrick Davies A-Frame automatic picking system, Symbion Keysborough facility, 9 Melbourne, Australia
Slide 10: EBOS Strategic Approach
EBOS Strategic Approach For personal use only Our Healthcare and Animal Care strategic focus is centred on Disciplined Capital Investing for Growth Leading Market Positions Management Two types of investments: We aim to have positions of scale • Cash generation to drive scope for • Acquisitions – we
Slide 11: Investment Highlights
Investment Highlights Acquisitions Capacity Expansion For personal use only TWC Investment: October 2016 Significant progress made in FY17 on two key • Merger of Chemmart and Terry White has capex projects in Australia created of one of the largest retail • New Wholesale Distribution site pharmacy s
Slide 12: Corporate video
Corporate video For personal use only • The corporate video that will be shown at the Annual Meeting can be viewed on the EBOS Group website at www.ebosgroup.com 12
Slide 13: FY17 Segment Performance - Healthcare
FY17 Segment Performance - Healthcare For personal use only Constant FX • Revenue increase of $516m or 9.8% (constant FX): NZ$m FY17 FY16 Var Var – Australia up 11.8% (or 4.1% excluding hepatitis Healthcare segment C medicine sales). Revenue 7,202.7 6,686.4 7.7% 9.8% – New Zealand up 2.4%. EBITDA 20
Slide 14: FY17 Segment Performance – Animal care
FY17 Segment Performance – Animal care For personal use only Constant FX NZ$m • EBITDA increase of $2.4m or 7.6% (constant FX) FY17 FY16 Var Var attributable to: Animal Care segment Revenue 423.2 415.0 2.0% 4.2% – Revenue growth from our key branded products; EBITDA 44.7 42.3 5.7% 7.6% • Black Hawk
Slide 15: FY18 Trading Update
FY18 Trading Update For personal use only • We have made a positive start to the first quarter of the 2018 financial year, with growth from both our Healthcare and Animal care segments. • On the basis of our current trading performance, we expect constant currency, underlying EBITDA for the 2018 fin
Slide 16: 2017 Annual Meeting: Business of the Meeting
For personal use only 2017 Annual Meeting 3 Business of the Meeting Selection of our branded products from Red Seal, Faulding, Vitapet and BlackHawk 16
Slide 17: Annual Report and Financial Statements
Item 1 Annual Report and Financial Statements For personal use only • To consider and receive the annual report and the financial statements for the year ended 30 June 2017 and the audit report thereon. 17
Slide 18: Director re-election – Stuart McGregor
Item 2 Director re-election – Stuart McGregor For personal use only To consider the re-election of Stuart McGregor as a director of the Company. Stuart McGregor retires by rotation and being eligible offers himself for re- election. Stuart McGregor BCOM, LLB, MBA Non-executive Director Stuart McGreg
Slide 19: Director re-election – Sarah Ottrey
Item 3 Director re-election – Sarah Ottrey For personal use only To consider the re-election of Sarah Ottrey as a director of the Company. Sarah Ottrey retires by rotation and being eligible offers herself for re-election. Sarah Ottrey BCOM Independent Director Sarah Ottrey was appointed to the EBOS
Slide 20: Auditor fees and expenses
Item 4 Auditor fees and expenses For personal use only • That the directors be authorised to fix the fees and expenses of Deloitte as the auditor of the Company. 20
Slide 21: Thank you for attending
For personal use only 2017 Annual Meeting Thank you for attending Please join us for refreshments www.ebosgroup.com